FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

395823000: Peginterferon alfa-2b (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469763016 Peginterferon alfa-2b (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1489464015 Peginterferon alfa-2b en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
4852441000005118 peginterferon alfa-2b da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Peginterferon alfa-2b (substance) Is a Interferon alfa-2b false Inferred relationship Some
Peginterferon alfa-2b (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some
Peginterferon alfa-2b (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiviral (disposition) true Inferred relationship Some
Peginterferon alfa-2b (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Interferon alfa-2b true Inferred relationship Some
Peginterferon alfa-2b (substance) Is a Interferon alfa (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing peginterferon alfa-2b (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Peginterferon alfa-2b (substance) Inferred relationship Some 1
peginterferon alfa-2b 50 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
peginterferon alfa-2b 80 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
peginterferon alfa-2b 100 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
peginterferon alfa-2b 150 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
peginterferon alfa-2b 120 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
PEG-intron redipen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
PEG-intron redipen 150 µg pulver + 0,5 ml sterilt vand The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
PEG-intron redipen 120 µg pulver + 0,5 ml sterilt vand The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
PEG-intron redipen 50 µg pulver + 0,5 ml sterilt vand The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
PEG-intron redipen 80 µg pulver + 0,5 ml sterilt vand The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
peginterferon alfa-2b 150 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
peginterferon alfa-2b 50 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
peginterferon alfa-2b 80 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
peginterferon alfa-2b 100 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
peginterferon alfa-2b 120 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
Product containing peginterferon alfa-2b in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Peginterferon alfa-2b (substance) Inferred relationship Some
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Peginterferon alfa-2b only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Peginterferon alfa-2b only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Peginterferon alfa-2b (substance) Inferred relationship Some 1
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Peginterferon alfa-2b (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start